Home ILEX Oncology

ILEX Oncology

acquired
IPO Delisting
Developer of Tumor Therapeutics
Basic
Enterprise Profile

Basic Information

ILEX Oncology specializes in the development of oncology therapeutic drugs. The company leverages its expertise in tumor drug identification, development, manufacturing, and regulatory approval processes to develop cancer treatment and prevention products, while providing contract research services to pharmaceutical and biotechnology companies.
ILEX Oncology, Inc.
SanAntonio,Texas,United States of America
101~500 people
January 01, 1992
--
--

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Biological Pharmaceutical Products
Technology
Biotechnology
Concept
Tumor
Application Scenarios
Drug Concepts